These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6481612)

  • 1. Prediction of blood levels following oral administration of weakly acidic drug particles such as sulfa drugs in rabbits from the in vitro dissolution behavior.
    Watari N; Kaneniwa N
    J Pharmacobiodyn; 1984 Jun; 7(6):351-65. PubMed ID: 6481612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary Dissolution of Poorly Soluble Compounds Studied in an ex Vivo Rat Lung Model.
    Eriksson J; Thörn H; Sjögren E; Holmstén L; Rubin K; Lennernäs H
    Mol Pharm; 2019 Jul; 16(7):3053-3064. PubMed ID: 31136181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of gastric pH on oral drug absorption: In vitro assessment using a dissolution/permeation system reflecting the gastric dissolution process.
    Kataoka M; Fukahori M; Ikemura A; Kubota A; Higashino H; Sakuma S; Yamashita S
    Eur J Pharm Biopharm; 2016 Apr; 101():103-11. PubMed ID: 26873006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro dissolution methodology, mini-Gastrointestinal Simulator (mGIS), predicts better in vivo dissolution of a weak base drug, dasatinib.
    Tsume Y; Takeuchi S; Matsui K; Amidon GE; Amidon GL
    Eur J Pharm Sci; 2015 Aug; 76():203-12. PubMed ID: 25978875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a Physiologically Relevant Population Pharmacokinetic in Vitro-in Vivo Correlation Approach for Designing Extended-Release Oral Dosage Formulation.
    Kim TH; Shin S; Bulitta JB; Youn YS; Yoo SD; Shin BS
    Mol Pharm; 2017 Jan; 14(1):53-65. PubMed ID: 27809538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of biorelevant dissolution and PBPK modeling to predict oral drug absorption.
    Kaur N; Narang A; Bansal AK
    Eur J Pharm Biopharm; 2018 Aug; 129():222-246. PubMed ID: 29879527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the enhanced oral bioavailability of fenofibrate lipid formulations in fasted humans using an in vitro-in silico-in vivo approach.
    Fei Y; Kostewicz ES; Sheu MT; Dressman JB
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1274-84. PubMed ID: 23500116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of oral absorption of griseofulvin, a BCS class II drug, based on GITA model: utilization of a more suitable medium for in-vitro dissolution study.
    Fujioka Y; Kadono K; Fujie Y; Metsugi Y; Ogawara K; Higaki K; Kimura T
    J Control Release; 2007 Jun; 119(2):222-8. PubMed ID: 17442444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Volume to dissolve applied dose (VDAD) and apparent dissolution rate (ADR): tools to predict in vivo bioavailability from orally applied drug suspensions.
    Muenster U; Pelzetter C; Backensfeld T; Ohm A; Kuhlmann T; Mueller H; Lustig K; Keldenich J; Greschat S; Göller AH; Gnoth MJ
    Eur J Pharm Biopharm; 2011 Aug; 78(3):522-30. PubMed ID: 21315152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In Silico Modeling Approach for the Evaluation of Gastrointestinal Dissolution, Supersaturation, and Precipitation of Posaconazole.
    Hens B; Pathak SM; Mitra A; Patel N; Liu B; Patel S; Jamei M; Brouwers J; Augustijns P; Turner DB
    Mol Pharm; 2017 Dec; 14(12):4321-4333. PubMed ID: 28817288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis and prediction of absorption behavior for theophylline orally administered as powders based on gastrointestinal-transit-absorption (Gita) model.
    Kadono K; Yokoe J; Ogawara K; Higaki K; Kimura T
    Drug Metab Pharmacokinet; 2002; 17(4):307-15. PubMed ID: 15618682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of particle dissolution rate on ocular drug bioavailability.
    Hui HW; Robinson JR
    J Pharm Sci; 1986 Mar; 75(3):280-7. PubMed ID: 3701612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous in vitro and in vivo evaluation of both trimethoprim and sulfamethoxazole from certain dosage forms.
    Meshali M; El-Sabbagh H; Ghanem A; Foda A
    Pharmazie; 1983 Jun; 38(6):403-6. PubMed ID: 6604284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting in vivo absorption behavior of oral modified release dosage forms containing pH-dependent poorly soluble drugs using a novel pH-adjusted biphasic in vitro dissolution test.
    Heigoldt U; Sommer F; Daniels R; Wagner KG
    Eur J Pharm Biopharm; 2010 Sep; 76(1):105-11. PubMed ID: 20472059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissolution of slightly soluble drugs. IV. Effect of particle size of sulfonamides on in vitro dissolution rate and in vivo absorption rate, and their relation to solubility.
    Kaneniwa N; Watari N
    Chem Pharm Bull (Tokyo); 1978 Mar; 26(3):813-26. PubMed ID: 647854
    [No Abstract]   [Full Text] [Related]  

  • 16. The biopharmaceutic drug classification and drugs administered in extended release (ER) formulations.
    Corrigan OI
    Adv Exp Med Biol; 1997; 423():111-28. PubMed ID: 9269487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
    Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
    Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Forecasting in vivo oral absorption and food effect of micronized and nanosized aprepitant formulations in humans.
    Shono Y; Jantratid E; Kesisoglou F; Reppas C; Dressman JB
    Eur J Pharm Biopharm; 2010 Sep; 76(1):95-104. PubMed ID: 20576487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of particle deposition density of dry powders on the results produced by an in vitro test system simulating dissolution- and absorption rates in the lungs.
    Malmlöf M; Nowenwik M; Meelich K; Rådberg I; Selg E; Burns J; Mascher H; Gerde P
    Eur J Pharm Biopharm; 2019 Jun; 139():213-223. PubMed ID: 30862480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preformulation characterization and in vivo absorption in beagle dogs of JFD, a novel anti-obesity drug for oral delivery.
    Fan Y; Yang M; Wang Y; Li Y; Zhou Y; Chen X; Shan L; Wei J; Gao C
    Drug Dev Ind Pharm; 2015 May; 41(5):801-11. PubMed ID: 24694186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.